CVSI CV Sciences Inc.

CV Sciences, Inc. engages in the development, manufacture, and sale of consumer and pharmaceutical products. It operates through the Consumer Products and Specialty Pharmaceutical segments. The Consumer Products segment includes manufacturing, marketing, and selling of hemp-based cannabidiol products through the PlusCBD brand. The Specialty Pharmaceutical segment focuses on developing cannabinoids to treat medical indications. The company was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in San Diego, CA.

This security is traded over-the-counter, or OTC. We don't always have accurate pricing data on OTC stocks.

$0.26    OTCQB
As of 09/15/2021     OTCMarkets


Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Micro cap
GICS sector:  Consumer Staples
Industry:  Drug Manufacturers—Specialty &
Index country:  USA
Country of incorporation:  
IPO date:  11/09/2011
Outstanding shares:  109,919,606
Average volume:  295,915
Market cap:   $28,469,178
Current dividend yield:  0.00%
All SEC filings:     SEC Edgar Online
Quarterly filings:   10-Q
Annual filings:      10-K
CUSIP:    
ISIN:        
Sedol:      
Valuation   (See tab for details)
PE ratio:   -1.48
PB ratio:   2.80
PS ratio:   1.37
Return on equity:   -191.52%
Net income %:   -92.15%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy